Ovarian follicle culture: advances and challenges for human and nonhuman primates
- PMID: 23635350
- PMCID: PMC3929501
- DOI: 10.1016/j.fertnstert.2013.03.043
Ovarian follicle culture: advances and challenges for human and nonhuman primates
Abstract
The removal and cryostorage of ovarian cortical biopsies is now offered as a fertility preservation option for young women. The only available option to restore fertility using this tissue is by transplantation, which may not be possible for all patients. The full potential of this tissue to restore fertility could be achieved by the development of in vitro systems that support oocyte development from the most immature stages to maturation. The techniques of in vitro growth (IVG) combined with in vitro maturation (IVM) are being developed with human tissue, but comparing different systems has been difficult because of the scarcity of tissue so nonhuman primates are being used as model systems. There are many challenges to developing a complete culture system that would support human oocyte development, and this review outlines the approaches being taken by several groups using tissue from women and nonhuman primate models to support each of the stages of oocyte development.
Copyright © 2013. Published by Elsevier Inc.
Figures
References
-
- Donnez J, Silber S, Andersen CY, Demeestere I, Piver P, Meirow D, Pellicer A, Dolmans MM. Children born after autotransplantation of cryopreserved ovarian tissue. A review of 13 live births. Ann Med. 2011;43:437–50. - PubMed
-
- Andersen CY, Kristensen SG, Greve T, Schmidt KT. Cryopreservation of ovarian tissue for fertility preservation in young female oncological patients. Future Oncol. 2012:8595–608. - PubMed
-
- Silber SJ, Barbey N. Scientific molecular basis for treatment of reproductive failure in the human: an insight into the future. Biochim Biophys Acta. 2012;1822:1981–96. - PubMed
-
- Eppig JJ, O’Brien MJ. Development in vitro of mouse oocytes from primordial follicles. Biol Reprod. 1996;54:197–207. - PubMed
Publication types
MeSH terms
Grants and funding
- RL1 HD058294/HD/NICHD NIH HHS/United States
- R01-HD058294/HD/NICHD NIH HHS/United States
- U54-HD18185/HD/NICHD NIH HHS/United States
- PL1 EB008542/EB/NIBIB NIH HHS/United States
- G0901839/MRC_/Medical Research Council/United Kingdom
- UL1 RR024926/RR/NCRR NIH HHS/United States
- HD058295/HD/NICHD NIH HHS/United States
- R01-HD058293/HD/NICHD NIH HHS/United States
- U54 HD018185/HD/NICHD NIH HHS/United States
- PL1-EB008542/EB/NIBIB NIH HHS/United States
- P51 OD011092/OD/NIH HHS/United States
- G0901839/1/MRC_/Medical Research Council/United Kingdom
- RL1 HD058293/HD/NICHD NIH HHS/United States
- RL1 HD058295/HD/NICHD NIH HHS/United States
- 8P51OD011092/OD/NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
